Now showing items 1-3 of 3

    • An Update on Hepatocellular Carcinoma in Chronic Kidney Disease 

      Ridruejo, Ezequiel.; Fabrizi, Fabrizio.; Cerutti, Roberta.; Et al. (MDPI [Commercial Publisher], 2021-07)
      Abstract Chronic kidney disease is a major public health issue globally and the risk of cancer (including HCC) is greater in patients on long-term dialysis and kidney transplant compared with the general population. ...
    • Hepatitis B virus vaccine and chronic kidney disease. The advances 

      Ridruejo, Ezequiel.; Fabrizi, Fabrizio.; Cerutti, Roberta.; Et al. (Sociedad española de nefrología, 2021-03)
      Abstract Background: Hepatitis B is an important agent of liver disease in patients with chronic kidney disease and chronic HBV infection promotes the development of CKD in the adult general population. Patients with CKD ...
    • 'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant 

      Mendizabal, Manuel.; Silva, Marcelo.; Fabrizi, Fabrizio.; Et al. (Elsevier, 2021-11)
      Abstract Introductions and objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the ...